A detailed history of Choreo, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Choreo, LLC holds 30,486 shares of LLY stock, worth $24.3 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
30,486
Previous 27,933 9.14%
Holding current value
$24.3 Million
Previous $25.3 Million 6.8%
% of portfolio
0.4%
Previous 0.43%

Shares

40 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $1.97 Million - $2.45 Million
2,553 Added 9.14%
30,486 $27 Million
Q2 2024

Aug 06, 2024

BUY
$724.87 - $909.04 $14.3 Million - $17.9 Million
19,704 Added 239.45%
27,933 $25.3 Million
Q1 2024

May 02, 2024

SELL
$592.2 - $792.28 $245,170 - $328,003
-414 Reduced 4.79%
8,229 $6.4 Million
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $1.19 Million - $1.4 Million
2,257 Added 35.34%
8,643 $5.04 Million
Q3 2023

Nov 08, 2023

SELL
$434.7 - $599.3 $20,865 - $28,766
-48 Reduced 0.75%
6,386 $3.43 Million
Q2 2023

Aug 04, 2023

BUY
$350.74 - $468.98 $43,141 - $57,684
123 Added 1.95%
6,434 $3.02 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $1.38 Million - $1.62 Million
4,433 Added 236.05%
6,311 $2.17 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $219,940 - $256,274
684 Added 57.29%
1,878 $687,000
Q3 2022

Oct 21, 2022

SELL
$296.48 - $337.87 $592 - $675
-2 Reduced 0.17%
1,194 $386,000
Q2 2022

Aug 11, 2022

SELL
$278.73 - $327.27 $88,357 - $103,744
-317 Reduced 20.95%
1,196 $388,000
Q1 2022

May 02, 2022

BUY
$234.69 - $291.66 $85,661 - $106,455
365 Added 31.79%
1,513 $433,000
Q4 2021

Feb 08, 2022

BUY
$224.85 - $279.04 $37,100 - $46,041
165 Added 16.79%
1,148 $317,000
Q3 2021

Nov 08, 2021

SELL
$221.6 - $272.71 $5,983 - $7,363
-27 Reduced 2.67%
983 $227,000
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $182,355 - $235,875
1,010 New
1,010 $232,000
Q3 2020

Nov 03, 2020

SELL
$146.22 - $169.13 $200,028 - $231,369
-1,368 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $58,387 - $70,269
-428 Reduced 23.83%
1,368 $225,000
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $28,333 - $35,069
-238 Reduced 11.7%
1,796 $249,000
Q4 2019

Jun 04, 2020

BUY
$106.92 - $132.43 $217,475 - $269,362
2,034 New
2,034 $267,000
Q2 2019

Jun 04, 2020

SELL
$110.79 - $129.32 $177,707 - $207,429
-1,604 Closed
0 $0
Q1 2019

Jun 04, 2020

SELL
$111.31 - $131.02 $176,203 - $207,404
-1,583 Reduced 49.67%
1,604 $208,000
Q4 2018

Jun 04, 2020

SELL
$105.9 - $118.64 $50,514 - $56,591
-477 Reduced 13.02%
3,187 $369,000
Q3 2018

Jun 04, 2020

BUY
$85.86 - $107.31 $7,813 - $9,765
91 Added 2.55%
3,664 $393,000
Q2 2018

Jun 04, 2020

SELL
$75.7 - $86.88 $94,246 - $108,165
-1,245 Reduced 25.84%
3,573 $305,000
Q1 2018

Jun 04, 2020

SELL
$74.21 - $87.6 $12,838 - $15,154
-173 Reduced 3.47%
4,818 $373,000
Q4 2017

Jun 04, 2020

SELL
$81.94 - $87.89 $79,235 - $84,989
-967 Reduced 16.23%
4,991 $422,000
Q3 2017

Jun 04, 2020

SELL
$77.07 - $85.54 $193,676 - $214,962
-2,513 Reduced 29.67%
5,958 $510,000
Q2 2017

Jun 04, 2020

SELL
N/A
-244 Reduced 2.8%
8,471 $697,000
Q1 2017

Jun 04, 2020

BUY
N/A
3,195 Added 57.88%
8,715 $733,000
Q4 2016

Jun 04, 2020

SELL
N/A
-1,146 Reduced 17.19%
5,520 $406,000
Q3 2016

Jun 04, 2020

SELL
N/A
-42 Reduced 0.63%
6,666 $535,000
Q2 2016

Jun 04, 2020

SELL
N/A
-17 Reduced 0.25%
6,708 $528,000
Q1 2016

Jun 04, 2020

SELL
N/A
-195 Reduced 2.82%
6,725 $484,000
Q4 2015

Jun 04, 2020

SELL
N/A
-303 Reduced 4.19%
6,920 $583,000
Q3 2015

Jun 04, 2020

BUY
N/A
831 Added 13.0%
7,223 $604,000
Q2 2015

Jun 04, 2020

BUY
N/A
28 Added 0.44%
6,392 $534,000
Q1 2015

Jun 04, 2020

BUY
N/A
409 Added 6.87%
6,364 $462,000
Q4 2014

Jun 04, 2020

SELL
N/A
-24 Reduced 0.4%
5,955 $411,000
Q3 2014

Jun 04, 2020

BUY
N/A
9 Added 0.15%
5,979 $388,000
Q2 2014

Jun 04, 2020

SELL
N/A
-222 Reduced 3.59%
5,970 $371,000
Q1 2014

Jun 04, 2020

BUY
N/A
6,192
6,192 $364,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Choreo, LLC Portfolio

Follow Choreo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choreo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Choreo, LLC with notifications on news.